1. Home
  2. ZURA vs GSIT Comparison

ZURA vs GSIT Comparison

Compare ZURA & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • GSIT
  • Stock Information
  • Founded
  • ZURA 2022
  • GSIT 1995
  • Country
  • ZURA United States
  • GSIT United States
  • Employees
  • ZURA N/A
  • GSIT N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • GSIT Semiconductors
  • Sector
  • ZURA Health Care
  • GSIT Technology
  • Exchange
  • ZURA Nasdaq
  • GSIT Nasdaq
  • Market Cap
  • ZURA 137.2M
  • GSIT 147.8M
  • IPO Year
  • ZURA N/A
  • GSIT N/A
  • Fundamental
  • Price
  • ZURA $3.34
  • GSIT $13.09
  • Analyst Decision
  • ZURA Buy
  • GSIT
  • Analyst Count
  • ZURA 9
  • GSIT 0
  • Target Price
  • ZURA $11.00
  • GSIT N/A
  • AVG Volume (30 Days)
  • ZURA 4.3M
  • GSIT 10.2M
  • Earning Date
  • ZURA 11-06-2025
  • GSIT 10-30-2025
  • Dividend Yield
  • ZURA N/A
  • GSIT N/A
  • EPS Growth
  • ZURA N/A
  • GSIT N/A
  • EPS
  • ZURA N/A
  • GSIT N/A
  • Revenue
  • ZURA N/A
  • GSIT $22,130,000.00
  • Revenue This Year
  • ZURA N/A
  • GSIT N/A
  • Revenue Next Year
  • ZURA N/A
  • GSIT N/A
  • P/E Ratio
  • ZURA N/A
  • GSIT N/A
  • Revenue Growth
  • ZURA N/A
  • GSIT 6.14
  • 52 Week Low
  • ZURA $0.97
  • GSIT $1.62
  • 52 Week High
  • ZURA $4.96
  • GSIT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 55.62
  • GSIT 79.00
  • Support Level
  • ZURA $3.18
  • GSIT $4.80
  • Resistance Level
  • ZURA $3.51
  • GSIT $18.14
  • Average True Range (ATR)
  • ZURA 0.36
  • GSIT 1.88
  • MACD
  • ZURA -0.08
  • GSIT 0.87
  • Stochastic Oscillator
  • ZURA 50.40
  • GSIT 64.15

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: